Orchard Therapeutics plc
ORTXNASDAQHealthcare
$16.70
+$0.05(+0.30%)
Market Cap$380108700
P/E Ratio—
52W High$16.72
52W Low$4.24
Orchard Therapeutics plc (ORTX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORTX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.99M | $0.48M | $2.60M | $2.51M | $2.08M |
| Cost of Revenue | $2.43M | $0.23M | $0.86M | $0.81M | $0.42M |
| Gross Profit | $4.55M | $0.26M | $1.74M | $1.71M | $1.65M |
| Gross Margin %(computed) | 65.17% | 53.21% | 66.97% | 67.97% | 79.67% |
| Operating Expenses | |||||
| R&D Expenses | $25.55M | $23.35M | $93.73M | $117.36M | $205.32M |
| G&A Expenses | $44.66M | $49.65M | $56.89M | $49.16M | $0.00M |
| Total Operating Expenses | $36.15M | $36.90M | $158.72M | $174.58M | $236.69M |
| Operating Income | ($31.59M) | ($36.41M) | ($156.98M) | ($172.87M) | ($235.03M) |
| Operating Margin %(computed) | -452.22% | — | — | — | — |
| Interest Income | $0.86M | $0.06M | $3.19M | $7.36M | $0.00M |
| Interest Expense | $0.93M | $0.68M | $2.33M | $1.54M | $0.00M |
| Income Before Tax | ($9.01M) | ($36.22M) | ($152.71M) | ($165.66M) | ($229.53M) |
| Income Tax Expense | ($1.13M) | $0.13M | ($0.73M) | ($2.24M) | $0.97M |
| Net Income | ($7.88M) | ($36.35M) | ($151.98M) | ($163.42M) | ($230.50M) |
| Net Margin %(computed) | -112.84% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.61 | $-2.93 | $-15.28 | $-17.53 | $-102.17 |
| Wtd Avg Shares | 12.80M | 12.40M | 9.94M | 9.32M | 2.26M |
| EBITDA | ($8.08M) | ($35.54M) | ($148.38M) | ($155.38M) | ($235.03M) |
| EBITDA Margin %(computed) | -115.65% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Orchard Therapeutics plc data
About Orchard Therapeutics plc (ORTX) Income Statement
Orchard Therapeutics plc (ORTX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ORTX reported revenue of $0.01B, gross profit of $0.00B (gross margin 65.17%), and net income of ($0.01B) — a net profit margin of -112.84%.
Frequently asked questions
ORTX · 4 questionsOrchard Therapeutics plc (ORTX) reported revenue of $0.01B for 2022, up 1346.4% year-over-year.
ORTX revenueORTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09